Skip to main content
. 2015 Apr 15;10(5):408–417. doi: 10.1080/15592294.2015.1039221

Table 3.

PCR and pyrosequencing primers

NR3C1 1F Assay 2 – CpG sites 5–1 - chr5:143,404,013–143,404,147*
PCR primer forward- Biotinylated /5Biosg/ GTTGTTATTAGTAGGGGTATTGG
PCR primer reverse AACCACCCAATTTCTCCAATTTCTTTTC
Pyrosequencing primer (reverse) CAACTCCCCCACTCCAAACCC
NR3C1 1F Assay 1 – CpG sites 6–10 - chr5:143,404,011–143,404,097*  
PCR primer forward AGTTTTAGAGTGGGTTTGGAG
PCR primer reverse-Biotinylated /5Biosg/ AAAACCACCCAATTTCTCCAATTTCTT
Pyrosequencing primer (forward) GAGTGGGTTTGGAGT
BDNF IV – CpG sites 1–5 - chr11:27,701,519–27,701,826*
PCR primer forward GGGTTGGAAGTGAAAATATTTGTAAA
PCR primer reverse-Biotinylated /5Biosg/CCCCATCAACCAAAAACTCCATTTAATCTC
Pyrosequencing primer (forward) GGTAGAGGAGGTATTATATGATAG
*

Genomic coordinates show genomic regions amplified by PCR and are based on the UCSC Genome Browser Human Dec. 2013 (GRCh38/hg38) Assembly.